What amount sold does BIOINCEPT LLC report in Form D filings?

The latest linked filings report $15.6M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was BIOINCEPT LLC's most recent SEC filing?

BIOINCEPT LLC's most recent Form D filing was on 2020-10-20.

How many investors does BIOINCEPT LLC have?

The most recent Form D filing lists 28 investor(s).

What type of securities does BIOINCEPT LLC offer?

BIOINCEPT LLC's SEC Form D filings indicate equity, debt offerings.

BIOINCEPT LLC

CIK: 0001401750·Biotechnology·NEW YORK, NY·Limited Liability Company

Reported Sold

$15,588,857

Total Filings

Identified Offerings

Last Filed

Oct 20, 2020

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Oct 20, 2020Form D — New notice

Reported sold: $3,100,000 · Target: $15,000,000

Rule 506(c)·28 investors

Mar 7, 2019Form D — New notice

Reported sold: $2,019,100 · Target: $8,000,000

Rule 506(b)·17 investors

Dec 1, 2016Form D/A — Amendment

Reported sold: $7,284,757 · Target: $7,284,757

Rule 506(b)·38 investors

Changed: Reported amount sold, Offering target, Reported investors

Sep 2, 2016Form D — New notice

Reported sold: $0 · Target: $13,533,445

Rule 506(b)·0 investors

Apr 28, 2014Form D/A — Amendment

Reported sold: $3,185,000 · Target: $6,500,000

Rule 506(c)·39 investors

Changed: Reported amount sold, Reported investors, Exemptions

Aug 27, 2013Form D — New notice

Reported sold: $1,845,000 · Target: $6,500,000

Rule 506·31 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 4 identified offerings

$15,588,857

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Dennis Spink

Related Person

Appears on 4 filings

George W. Frank

Related Person

Appears on 4 filings

Jacqueline H. Barnea

Related Person

Appears on 4 filings

Barton O'Brien

Related Person

Appears on 4 filings

Eytan R. Barnea

Related Person

Appears on 2 filings

Julia Corelli

Related Person

Appears on 2 filings

Eytan Barnea

Related Person

Appears on 2 filings

Jacqueline H Barnea

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 20, 2020	New	$15,000,000	$3,100,000	28
Mar 7, 2019	New	$8,000,000	$2,019,100	17
Dec 1, 2016	Amendment	$7,284,757	$7,284,757	38
Sep 2, 2016	New	$13,533,445	$0	0
Apr 28, 2014	Amendment	$6,500,000	$3,185,000	39
Aug 27, 2013	New	$6,500,000	$1,845,000	31

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

CAD Therapeutics, Inc.

Biotechnology

Offering target: $10,000,000

Filed Oct 1, 2026